118 related articles for article (PubMed ID: 36167773)
21. Familial colorectal cancer risk in half siblings and siblings: nationwide cohort study.
Tian Y; Kharazmi E; Sundquist K; Sundquist J; Brenner H; Fallah M
BMJ; 2019 Mar; 364():l803. PubMed ID: 30872356
[TBL] [Abstract][Full Text] [Related]
22. Hereditary prostate cancer and other genetic predispositions to prostate cancer.
Cussenot O; Valeri A; Berthon P; Fournier G; Mangin P
Urol Int; 1998; 60 Suppl 2():30-4; discussion 35. PubMed ID: 9607556
[TBL] [Abstract][Full Text] [Related]
23. Concordant and discordant familial cancer: Familial risks, proportions and population impact.
Frank C; Sundquist J; Yu H; Hemminki A; Hemminki K
Int J Cancer; 2017 Apr; 140(7):1510-1516. PubMed ID: 28006863
[TBL] [Abstract][Full Text] [Related]
24. [Prospective evaluation of prostate cancer screening in men with a family history of the disease].
Paiss T; Herkommer K; Kahn D; Gschwend JE; Küfer R; Maier C; Vogel W; Högel J; Hautmann RE
Urologe A; 2006 Aug; 45(8):1002-5. PubMed ID: 16830128
[TBL] [Abstract][Full Text] [Related]
25. Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative.
Beebe-Dimmer JL; Yee C; Paskett E; Schwartz AG; Lane D; Palmer NRA; Bock CH; Nassir R; Simon MS
BMC Cancer; 2017 Dec; 17(1):848. PubMed ID: 29237415
[TBL] [Abstract][Full Text] [Related]
26. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives.
Valeri A; Fournier G; Morin V; Morin JF; Drelon E; Mangin P; Teillac P; Berthon P; Cussenot O
Int J Cancer; 2000 Jun; 86(6):883-7. PubMed ID: 10842206
[TBL] [Abstract][Full Text] [Related]
27. Search for familial clustering of multiple myeloma with any cancer.
Frank C; Fallah M; Chen T; Mai EK; Sundquist J; Försti A; Hemminki K
Leukemia; 2016 Mar; 30(3):627-32. PubMed ID: 26449663
[TBL] [Abstract][Full Text] [Related]
28. Patient and tumor characteristics may raise clinicians' awareness of familial colorectal cancer: a Norwegian population-based study.
Tranø G; Wasmuth H; Sjursen W; Vatten L
Scand J Gastroenterol; 2011 Oct; 46(10):1236-42. PubMed ID: 21679123
[TBL] [Abstract][Full Text] [Related]
29. Familial aggregation of early-onset cancers.
Heikkinen SMM; Madanat-Harjuoja LM; Seppä KJM; Rantanen ME; Hirvonen EM; Malila NK; Pitkäniemi JM
Int J Cancer; 2020 Apr; 146(7):1791-1799. PubMed ID: 31199509
[TBL] [Abstract][Full Text] [Related]
30. Familial risk of early and late onset cancer: nationwide prospective cohort study.
Kharazmi E; Fallah M; Sundquist K; Hemminki K
BMJ; 2012 Dec; 345():e8076. PubMed ID: 23257063
[TBL] [Abstract][Full Text] [Related]
31. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study.
Nuako KW; Ahlquist DA; Mahoney DW; Schaid DJ; Siems DM; Lindor NM
Gastroenterology; 1998 Nov; 115(5):1079-83. PubMed ID: 9797361
[TBL] [Abstract][Full Text] [Related]
32. [Men with breast cancer have increased risk of other cancers].
Lorphelin H; Mortemousque I; Marret H; Body G; Ouldamer L
Presse Med; 2014 Apr; 43(4 Pt 1):e33-8. PubMed ID: 24612706
[TBL] [Abstract][Full Text] [Related]
33. Endometriosis related to family history of malignancies in the Yale series.
Matalliotakis IM; Cakmak H; Krasonikolakis GD; Dermitzaki D; Fragouli Y; Vlastos G; Arici A
Surg Oncol; 2010 Mar; 19(1):33-7. PubMed ID: 19299121
[TBL] [Abstract][Full Text] [Related]
34. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.
Sellers TA; Potter JD; Rich SS; Drinkard CR; Bostick RM; Kushi LH; Zheng W; Folsom AR
J Natl Cancer Inst; 1994 Dec; 86(24):1860-5. PubMed ID: 7990161
[TBL] [Abstract][Full Text] [Related]
35. Familial risk and familial survival in prostate cancer.
Hemminki K
World J Urol; 2012 Apr; 30(2):143-8. PubMed ID: 22116601
[TBL] [Abstract][Full Text] [Related]
36. Genetic epidemiology of colorectal cancer and associated cancers.
Yu H; Hemminki K
Mutagenesis; 2020 Jul; 35(3):207-219. PubMed ID: 31424514
[TBL] [Abstract][Full Text] [Related]
37. [Comparative study on risk factors and family history of familial and sporadic nasopharyngeal carcinoma patients].
Luo XY; Liu WS; Chen LZ; Feng QS; Zeng YX; Jia WH
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):293-8. PubMed ID: 19534949
[TBL] [Abstract][Full Text] [Related]
38. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
Peters CA; Stock RG; Blacksburg SR; Stone NN
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):24-9. PubMed ID: 18692325
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological differences between familial colorectal cancer type X and sporadic cancer in an isolated area of spain.
Medina-Arana V; Rahy-Martín A; Delgado-Plasencia L; Martínez-Riera A; León-Ayllón D; Rodríguez-Castellano D; Bravo-Gutiérrez A; Fernández-Peralta A; González-Aguilera JJ
Colorectal Dis; 2016 Nov; 18(11):O388-O396. PubMed ID: 27671100
[TBL] [Abstract][Full Text] [Related]
40. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
